FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041191077> ?p ?o ?g. }

• W3041191077 endingPage "830" @default.
• W3041191077 startingPage "819" @default.
• W3041191077 abstract "Little is known about opioid and gabapentinoid (OPI-GABA) use duration and dose patterns' associations with adverse outcome risks. We examined associations between OPI-GABA dose and duration trajectories and subsequent drug overdose.Retrospective cohort study.US Medicare.Using a 5% sample (2011-16), we identified 71 005 fee-for-service Medicare beneficiaries with fibromyalgia, low back pain, neuropathy and/or osteoarthritis initiating OPIs and/or GABAs [mean age ± standard deviation (SD) = 65.5 ± 14.5 years, female = 68.1%, white = 76.8%].Group-based multi-trajectory models identified distinct OPI-GABA use patterns during the year of OPI and/or GABA initiation, based on weekly average standardized daily dose (i.e. OPIs = morphine milligram equivalent, GABAs = minimum effective daily dose). We estimated models with three to 12 trajectories and selected the best model based on Bayesian information criterion (BIC) and Nagin's criteria. We estimated risk of time to first drug overdose diagnosis within 12 months following the index year, adjusting for socio-demographic and health factors using inverse probability of treatment weighted multivariable Cox proportional hazards models.We identified 10 distinct trajectories (BIC = -1 176 954; OPI-only = 3, GABA-only = 3, OPI-GABA = 4). Compared with OPI-only early discontinuers (40.6% of the cohort), 1-year drug overdose risk varied by trajectory group: consistent low-dose OPI-only users [16.6%; hazard ratio (HR) = 1.47, 95% confidence interval (CI) = 1.19-1.82], consistent high-dose OPI-only users (1.8%; HR = 4.57, 95% CI = 2.99-6.98), GABA-only early discontinuers (12.5%; HR = 1.39, 95% CI = 1.09-1.77), consistent low-dose GABA-only users (11.0%; HR = 1.44, 95% CI = 1.12-1.85), consistent high-dose GABA-only users (3.1%; HR = 1.43, 95% CI = 0.94-2.17), early discontinuation of OPIs and consistent low-dose GABA users (6.9%; HR = 1.24, 95% CI = 0.90-1.69), consistent low-dose OPI-GABA users (3.4%; HR = 2.49, 95% CI = 1.76-3.52), consistent low-dose OPI and high-dose GABA users (3.2%; HR = 2.46, 95% CI = 1.71-3.53) and consistent high-dose OPI and moderate-dose GABA users (0.9%; HR = 7.22, 95% CI = 4.46-11.69).Risk of drug overdose varied substantially among US Medicare beneficiaries on different use trajectories of opioids and gabapentinoids. High-dose opioid-only users and all consistent opioid and gabapentinoid users (regardless of doses) had more than double the risk of subsequent drug overdose compared with opioid-only early discontinuers." @default.
• W3041191077 created "2020-07-16" @default.
• W3041191077 creator A5002622252 @default.
• W3041191077 creator A5025147406 @default.
• W3041191077 creator A5025461512 @default.
• W3041191077 creator A5026440477 @default.
• W3041191077 creator A5033233100 @default.
• W3041191077 creator A5033488223 @default.
• W3041191077 creator A5045677026 @default.
• W3041191077 creator A5067710734 @default.
• W3041191077 creator A5078547326 @default.
• W3041191077 creator A5084386025 @default.
• W3041191077 date "2020-08-19" @default.
• W3041191077 modified "2023-10-14" @default.
• W3041191077 title "Dual‐trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study" @default.
• W3041191077 cites W108761767 @default.
• W3041191077 cites W1966714873 @default.
• W3041191077 cites W1983926592 @default.
• W3041191077 cites W1991298345 @default.
• W3041191077 cites W1997944093 @default.
• W3041191077 cites W2024012275 @default.
• W3041191077 cites W2028103928 @default.
• W3041191077 cites W2036193982 @default.
• W3041191077 cites W2055432693 @default.
• W3041191077 cites W2059944344 @default.
• W3041191077 cites W2079250246 @default.
• W3041191077 cites W2086396791 @default.
• W3041191077 cites W2096716094 @default.
• W3041191077 cites W2107472322 @default.
• W3041191077 cites W2107662809 @default.
• W3041191077 cites W2113651274 @default.
• W3041191077 cites W2118199884 @default.
• W3041191077 cites W2121487587 @default.
• W3041191077 cites W2142974976 @default.
• W3041191077 cites W2196451120 @default.
• W3041191077 cites W2273108584 @default.
• W3041191077 cites W2466896638 @default.
• W3041191077 cites W2529531782 @default.
• W3041191077 cites W2537977980 @default.
• W3041191077 cites W2593625039 @default.
• W3041191077 cites W2599076725 @default.
• W3041191077 cites W2610104393 @default.
• W3041191077 cites W2612986561 @default.
• W3041191077 cites W2613593111 @default.
• W3041191077 cites W2735301415 @default.
• W3041191077 cites W2738210000 @default.
• W3041191077 cites W2740244424 @default.
• W3041191077 cites W2755477883 @default.
• W3041191077 cites W2756978732 @default.
• W3041191077 cites W2760847338 @default.
• W3041191077 cites W2761666829 @default.
• W3041191077 cites W2763928864 @default.
• W3041191077 cites W2771119796 @default.
• W3041191077 cites W2782300316 @default.
• W3041191077 cites W2809119374 @default.
• W3041191077 cites W2888071069 @default.
• W3041191077 cites W2895470650 @default.
• W3041191077 cites W2896026881 @default.
• W3041191077 cites W2906863571 @default.
• W3041191077 cites W2914307537 @default.
• W3041191077 cites W2924338030 @default.
• W3041191077 cites W2980401593 @default.
• W3041191077 cites W4236269788 @default.
• W3041191077 cites W4292229870 @default.
• W3041191077 doi "https://doi.org/10.1111/add.15189" @default.
• W3041191077 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7796992" @default.
• W3041191077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32648951" @default.
• W3041191077 hasPublicationYear "2020" @default.
• W3041191077 type Work @default.
• W3041191077 sameAs 3041191077 @default.
• W3041191077 citedByCount "22" @default.
• W3041191077 countsByYear W30411910772020 @default.
• W3041191077 countsByYear W30411910772021 @default.
• W3041191077 countsByYear W30411910772022 @default.
• W3041191077 countsByYear W30411910772023 @default.
• W3041191077 crossrefType "journal-article" @default.
• W3041191077 hasAuthorship W3041191077A5002622252 @default.
• W3041191077 hasAuthorship W3041191077A5025147406 @default.
• W3041191077 hasAuthorship W3041191077A5025461512 @default.
• W3041191077 hasAuthorship W3041191077A5026440477 @default.
• W3041191077 hasAuthorship W3041191077A5033233100 @default.
• W3041191077 hasAuthorship W3041191077A5033488223 @default.
• W3041191077 hasAuthorship W3041191077A5045677026 @default.
• W3041191077 hasAuthorship W3041191077A5067710734 @default.
• W3041191077 hasAuthorship W3041191077A5078547326 @default.
• W3041191077 hasAuthorship W3041191077A5084386025 @default.
• W3041191077 hasBestOaLocation W30411910772 @default.
• W3041191077 hasConcept C126322002 @default.
• W3041191077 hasConcept C167135981 @default.
• W3041191077 hasConcept C170493617 @default.
• W3041191077 hasConcept C201903717 @default.
• W3041191077 hasConcept C207103383 @default.
• W3041191077 hasConcept C2781063702 @default.
• W3041191077 hasConcept C44249647 @default.
• W3041191077 hasConcept C50382708 @default.
• W3041191077 hasConcept C71924100 @default.
• W3041191077 hasConcept C72563966 @default.
• W3041191077 hasConceptScore W3041191077C126322002 @default.

• next